Celldex Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
February 04 2016 - 04:01PM
Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that
Anthony Marucci, Co-founder, President and Chief Executive Officer,
and Thomas Davis, M.D., Executive Vice President and Chief Medical
Officer, will participate in a fireside chat at the Leerink
Partners 5th Annual Global Healthcare Conference on Thursday,
February 11, 2016 at 2:40 p.m. EST in New York City.
The live webcast of the presentation will be available on the
"Events & Presentations" page of the "Investors & Media"
section of the Celldex website. A replay of the presentation will
be available for seven days following the event.
About Celldex Therapeutics, Inc.Celldex is
developing targeted therapeutics to address devastating diseases
for which available treatments are inadequate. Our pipeline is
built from a proprietary portfolio of antibodies and
immunomodulators used alone and in strategic combinations to create
novel, disease-specific therapies that induce, enhance or suppress
the body's immune response. Visit www.celldex.com.
Contact
Sarah Cavanaugh
Vice President of Investor Relations & Corp Communications
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Celldex Therapeutics (NASDAQ:CLDX)
Historical Stock Chart
From Mar 2023 to Mar 2024